Testing Alpha-1 Antitrypsin Deficiency in Black Populations

Area of Science:

• Genetics
• Pulmonology
• Public Health

Background:

• Alpha-1 antitrypsin deficiency (AATD) is an inherited condition linked to chronic obstructive pulmonary disease (COPD).
• The SERPINA1 gene encodes alpha-1 antitrypsin (AAT), with severe mutations increasing COPD risk.
• Current AATD screening predominantly targets non-Hispanic White populations, potentially overlooking other ethnic groups.

Purpose of the Study:

• To review AATD and allele frequency in Black populations.
• To discuss clinical outcomes associated with low AATD screening rates in this demographic.
• To investigate whether low diagnosis rates stem from insufficient screening or genuinely low mutation frequencies.

Main Methods:

• Literature review of AATD and SERPINA1 mutation frequency.
• Analysis of epidemiological data concerning AATD in Black populations.
• Examination of health inequity and clinical implications of under-diagnosis.

Main Results:

• AATD is observed in Black populations, but mutation frequency data is scarce.
• Health inequities may exacerbate the impact of undiagnosed AATD in Black individuals.
• Low screening rates are a significant concern, potentially masking true prevalence.

Conclusions:

• Further research is needed to accurately determine AATD prevalence in Black populations.
• Increased screening and awareness are crucial to address health disparities related to AATD.
• Timely diagnosis and treatment of AATD are vital for improving health outcomes and reducing COPD burden.